Singapore HSA released registration requirements on Next Generation Sequencing IVDs

Singapore, Health Sciences Authority (HSA) released the final document on Next Generation Sequencing NGS IVDs.

This document focuses on the requirements of NGS IVDs for registrations.

The scope covers both NGS based IVD tests intended to aid in the diagnosis of individuals with suspected germline or somatic mutation-related diseases and NGS based tumor profiling IVD tests.

These guidelines add to the list of the Product-Specific Regulatory Guidelines:

•                    Telehealth Products
•                    FAQ Telehealth Products
•                    Aesthetic-Related Guidelines

The guidelines can be found at

Share on Linkedin Send to Email

Questions? Request more information from our specialists!

Contact Us

More News